Perinatal Hepatitis B
- Perinatal Hepatitis B Home
- About Perinatal Hepatitis B
- For Health Professionals
- Minnesota Program & Statistics
Minnesota Perinatal Hepatitis B Program and Statistics
We implemented a perinatal hepatitis B prevention program in 1990. Our goal is to identify and treat infants born to hepatitis B-positive people in an effort to prevent perinatally acquired infection. The benefits of this cost-effective strategy are preventing potential long-term health consequences for the child and eliminating a potential source of infection to others in the future.
The program provides case management to infants born to hepatitis B positive people. Of these infants, over 99% received treatment (consisting of vaccine and hepatitis B immune globulin) at birth.
Hepatitis B is transmitted very efficiently from an infected birthing parent to the infant at birth. If infected, up to 90% of babies will develop chronic hepatitis B infection which can lead to liver damage, liver failure, liver cancer and even death. Treatment initiated within 12 hours after birth is up to 94% effective at preventing this serious infection. Prevention efforts depend upon maintaining high treatment rates.
|Year||Number of infants born to hepatitis B-positive people in MN||Number of infants identified as hepatitis B-positive during reporting year|
Disease Control Newsletter (DCN)
Disease Control Newsletter (DCN) is MDH's surveillance information on certain communicable diseases in Minnesota.
- Disease Control Newsletter (DCN)
The DCN archives available on the web include 1997-2020.